Ribavirin enhances interferon-stimulated
β
Qiuwei Pan; Hugo W. Tilanus; Harry L.A. Janssen; Luc J. W. van der Laan
π
Article
π
2011
π
John Wiley and Sons
π
English
β 378 KB
We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6